Aggressive Non-Hodgkin Lymphoma
Item
one of the following biopsy-confirmed, aggressive non-hodgkin's lymphoma
boolean
C1332225 (UMLS CUI [1])
Diffuse Large B-Cell Lymphoma
Item
1. diffuse large b-cell lymphoma
boolean
C0079744 (UMLS CUI [1])
B-Cell Lymphoma Mediastinal Thymic
Item
2. mediastinal (thymic) b-cell lymphoma
boolean
C0079731 (UMLS CUI [1,1])
C1522718 (UMLS CUI [1,2])
C0040113 (UMLS CUI [1,3])
Ann Arbor lymphoma staging system
Item
any stage (i through iv) as defined by the ann arbor staging system
boolean
C0432516 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status of 0 to 2
boolean
C1520224 (UMLS CUI [1])
Measurable Disease Radiographic
Item
radiographically measurable disease
boolean
C1513041 (UMLS CUI [1,1])
C0444708 (UMLS CUI [1,2])
Chemotherapy cycle Quantity Lymphoma
Item
no more than 3 cycles of chemotherapy for lymphoma
boolean
C1302181 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0024299 (UMLS CUI [1,3])
Age
Item
greater than or equal to 18 years
boolean
C0001779 (UMLS CUI [1])
Pulmonary function | Cardiac function | Liver function | Renal function
Item
adequate pulmonary, cardiac, hepatic, or renal function
boolean
C0231921 (UMLS CUI [1])
C0232164 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
C0232804 (UMLS CUI [4])
HIV antibody negative
Item
hiv antibody negative
boolean
C1142096 (UMLS CUI [1])
Gender | Pregnancy Absent | Breast Feeding Absent
Item
women- not pregnant or breastfeeding
boolean
C0079399 (UMLS CUI [1])
C0032961 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0006147 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Gender Fertility Contraceptive methods
Item
men of reproductive potential must agree to use contraception
boolean
C0079399 (UMLS CUI [1,1])
C0015895 (UMLS CUI [1,2])
C0700589 (UMLS CUI [1,3])
Aggressive Lymphoma
Item
patients with the following aggressive lymphomas are not eligible:
boolean
C1332225 (UMLS CUI [1])
Mantle cell lymphoma
Item
1. mantle cell
boolean
C0334634 (UMLS CUI [1])
Lymphoblastic lymphoma
Item
2. lymphoblastic
boolean
C0079748 (UMLS CUI [1])
Burkitt Lymphoma
Item
3. burkitt's
boolean
C0006413 (UMLS CUI [1])
Mycosis Fungoides | Sezary Syndrome
Item
4. mycosis fungoides/sezary's syndrome
boolean
C0026948 (UMLS CUI [1])
C0036920 (UMLS CUI [2])
T-Cell Leukemia Associated with HTLV-1 | T-Cell Lymphoma Associated with HTLV-1
Item
5. htlv-1 associated t-cell leukemia/lymphoma
boolean
C0023492 (UMLS CUI [1,1])
C0332281 (UMLS CUI [1,2])
C0020094 (UMLS CUI [1,3])
C0079772 (UMLS CUI [2,1])
C0332281 (UMLS CUI [2,2])
C0020094 (UMLS CUI [2,3])
Primary central nervous system lymphoma
Item
6. primary cns lymphoma
boolean
C0280803 (UMLS CUI [1])
HIV associated lymphoma
Item
7. hiv-associated lymphoma
boolean
C0085090 (UMLS CUI [1])
Lymphoma transformation
Item
8. transformed lymphomas
boolean
C1536010 (UMLS CUI [1])
Lymphoma Associated with Immunodeficiency
Item
9. immunodeficiency-associated lymphomas
boolean
C0024299 (UMLS CUI [1,1])
C0332281 (UMLS CUI [1,2])
C0021051 (UMLS CUI [1,3])
Prior diagnosis Hematologic Neoplasm
Item
previous diagnosis of another hematologic malignancies
boolean
C0332132 (UMLS CUI [1,1])
C0376545 (UMLS CUI [1,2])
CHOP regimen Progressive Disease | Rituximab CHOP regimen Progressive Disease
Item
progressive disease on chop or rituximab-chop
boolean
C0163868 (UMLS CUI [1,1])
C1335499 (UMLS CUI [1,2])
C0393022 (UMLS CUI [2,1])
C0163868 (UMLS CUI [2,2])
C1335499 (UMLS CUI [2,3])
Central Nervous System Involvement Lymphoma
Item
active cns involvement by lymphoma
boolean
C4050309 (UMLS CUI [1,1])
C0024299 (UMLS CUI [1,2])
Comorbidity Serious | Study Subject Participation Status Excluded
Item
serious co-morbid disease that could preclude full participation in study
boolean
C0009488 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C2348568 (UMLS CUI [2,1])
C0332196 (UMLS CUI [2,2])